Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Apr 9, 2026
- Closes
- Feb 11, 2027 (in 120 days)
Similar opportunities open now
- Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)Same funderOpenNational Institutes of HealthCloses Nov 10, 2026 (in 27 days)Up to $100K
- DoW Tick-Borne Disease Therapeutic/Diagnostic Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses Oct 22, 2026
Classification and identifiers
- Solicitation number
- RFA-AI-28-024
- Assistance listing (CFDA)
- 93.855
Amount
Amount not listed here. Check the official program.
Who can apply
Nonprofits, including small and volunteer-run organizations, Local government agencies, and Private colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support basic research, discovery, and/or preclinical development of highly efficacious vaccines for malaria and potentially other mosquito-borne illness. The program will encourage novel approaches to vaccine design that capitalize on recent technological innovations including structure-based immunogen design, and/or combination vaccines to reduce parasite infection and/or reduce malaria disease burden. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.